Publications

(Displaying in Reverse Chronological Order)

1081
Kumar V, Rachamalla M, Nandekar P, Khatik GL, Sangamwar AT, Tikoo K, Nair VA. Design and synthesis of optically pure 3-aryl-6-methyl-2-thioxotetrahydropyrimidin-4(1 H)-ones as anti-prostate cancer agents RSC Advances 2014, 4, 37868-37877.
1082
1083
1084
Kumar V, Yadav N, Kartha KP. In(III) triflate-catalyzed detritylation and glycosylation by solvent-free ball milling Carbohydrate Research 2014, 397, 18-26.
1085
Kuncham S, Shete G, Bansal AK. Quantification of clarithromycin polymorphs in presence of tablet excipients Journal of Excipients and Food Chemicals 2014, 5, 65-78.
1086
Kurmi M, Kumar S, Singh B, Singh S. Implementation of design of experiments for optimization of forced degradation conditions and development of a stability-indicating method for furosemide Journal of Pharmaceutical and Biomedical Analysis 2014, 96, 135-143.
1087
Kushwaha S and Jena G. Effects of nicotine on the testicular toxicity of streptozotocin-induced diabetic rat: Intervention of enalapril Human and Experimental Toxicology 2014, 33, 609-622.
1088
1089
Laha JK, Dayal N, Singh S, Bhimpuria R. Dual Catalysis in Domino N-Benzylation/Intramolecular C-H Arylation: Regio- and Chemoselective Synthesis of Annelated Nitrogen Heterocycles European Journal of Organic Chemistry 2014, 2014, 5469-5475.
1090
1091
Laha JK, Satyanarayana Tummalapalli KS, Gupta A. Mechanistic insights into the palladium-catalyzed domino synthesis of 10,11-dihydro-5H-dibenzo[b,e][1,4]diazepines European Journal of Organic Chemistry 2014, 2014, 4773-4779.
1092
1093
Lakshmi PV, Sharma A, Bhatia D, Tikoo K, Kumar R. Dropsy outbreak in a single family in Punjab, India The American Journal of Tropical Medicine and Hygiene 2014, 91, 786-789.
1094
Lunagariya NA, Patel NK, Jagtap SC, Bhutani KK. Inhibitors of pancreatic lipase: State of the art and clinical perspectives EXCLI Journal 2014, 13, 897-921.
1095
Madan J, Gundala SR, Kasetti Y, Bharatam PV, Aneja R, Katyal A, Jain UK. Enhanced noscapine delivery using estrogen-receptor-targeted nanoparticles for breast cancer therapy Anti-Cancer Drugs 2014, 25, 704-716.